Thrive With Type 1 Diabetes 2026
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: TranS-C Intervention Arm, Attention Control Enhanced Usual Care (EUC) Arm.
- Who it may be relevant to
- Registry conditions: Type1diabetes. Basic parameters: 31 years — 75 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Intervention to Thrive With Type 1 Diabetes 2026
Overview
This study aims to learn whether a cognitive behavioral intervention can improve lifestyle and glucose targets for adults with type 1 diabetes.
Detailed description
Type 1 diabetes (T1D), a common yet understudied chronic condition in young adulthood, is a life-shortening disorder leading to beta-cell destruction and absolute insulin deficiency. Suboptimal glucose diabetes self-management is associated with a higher risk for premature vascular complications, both macrovascular (e.g., coronary artery disease, peripheral arterial disease, and stroke) and microvascular (retinopathy, nephropathy, neuropathy) through accelerated vascular aging. Yet a majority of adults with T1D do not achieve recommended glycemic targets (A1C \<7%) or blood pressure targets.
Interventions
- Behavioral TranS-C Intervention Arm
This 12-week cognitive behavioral intervention uses motivational interviewing and behavior change principles, focusing on self-efficacy and action planning. Participants target 7-9 hours of sleep per night, ≥85% sleep efficiency, and \<60 minutes' variability in bed and wake times. Components include sleep education and hygiene, nightly routines, the management of competing activities, sleep environment optimization, lifestyle modifications (e.g., avoiding caffeine and vigorous exercise before - Behavioral Attention Control Enhanced Usual Care (EUC) Arm
This time- and attention-balanced 12-week condition will focus on enhancing usual care. After the initial baseline visit, the RA for this group will schedule a 60-minute telehealth appointment for the enhanced usual care. Follow-up sessions (weeks 4 and 8) will focus on health perceptions, care plans, and relationship-building rather than sleep promotion. The RA will encourage participants to share their progress and confidence in their self-set goals to foster engagement and retention. Particip
Primary outcome measures
- Multidimensional sleep health composite score [Time frame: Baseline and post-intervention (14 weeks from baseline)]
- Glycated hemoglobin (HbA1C) [Time frame: Baseline and post-intervention (14 weeks from baseline)]
Secondary outcome measures (2)
- Glucose variability [Time frame: Baseline and post-intervention (14 weeks from baseline)]
- Time in range [Time frame: Baseline and post-intervention (14 weeks from baseline)]
Eligibility criteria
Inclusion criteria
- Aged 31 to 75 years
- Type 1 Diabetes for at least 1 year
- One or more sleep health dimensions are out of range
Exclusion criteria
- Non-English speaking
- Recent night shift work or transmeridian travel
- Life-limiting illness
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Other
Study locations
United States · 2 centers
- Emory University, Nell Hodgson Woodruff School of Nursing — Atlanta
- Emory University — Atlanta
Identifiers
NCT: NCT07522866 · 2026P000152